ABIVAX S.A.

ABVX11 Dec 2024
Healthcare
$8.38
-0.04 (-4.43%)
Lowest Today
$8.2
Highest Today
$8.38
Today’s Open
$8.38
Prev. Close
$8.58
52 Week High
$17.02
52 Week Low
$8.06
To Invest in ABIVAX S.A.

ABIVAX S.A.

Healthcare
ABVX11 Dec 2024
-0.04 (-4.43%)
1M
3M
6M
1Y
5Y
Low
$8.2
Day’s Range
High
$8.38
8.2
52 Week Low
$8.06
52-Week Range
52 Week High
$17.02
8.06
1 Day
-
1 Week
-3.37%
1 month return
-18.67%
3 month return
-27.1%
6 month return
-38.36%
1 Year return
-17.89%
3 Years return
-
5 Years return
-
10 Years return
-

Market Status

Fundamentals
Market Cap
649.94 mln
PB Ratio
2.69
PE Ratio
0
Enterprise Value
317.45 mln
Total Assets
327.06 mln
Volume

Company Financials

Fund house & investment objective

Company Information
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stablize the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis in adults. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.
Organisation
ABIVAX S.A.
Employees
62
Industry
Biotechnology
CEO
Mr. Marc M. P. de Garidel M.B.A.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities